Trials that use: Exact / Clopper-Pearson binomial
New to this method? Read the tutorial →
800 results
- A Study to Evaluate SAGE-217 in Participants With Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03000569).
- A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1)…
- A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement – (FIGHT-203): Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203): primary endpoint results, effect estimate with confidence…
- A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals’ Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously…
- A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults: primary endpoint results, effect estimate…
- A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of…
- A Study to Evaluate the Safety and Immunogenicity for Regimen Selection of Ad26.RSV.preF and/or RSV preF Protein Combinations Followed by Expanded Safety Evaluation in Adults Aged 60 Years and Older: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Safety and Immunogenicity for Regimen Selection of Ad26.RSV.preF and/or RSV preF Protein Combinations Followed by Expanded Safety Evaluation in Adults Aged 60 Years…
- A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson’s Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations: Complete Statistical AnalysisIndependent statistical analysis of A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing…
- A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy: primary endpoint…
- A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab: primary endpoint results, effect estimate with…
- A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment: primary endpoint results,…
- A Trial In Patients With Advanced Cancer And Leukemia: Complete Statistical AnalysisIndependent statistical analysis of A Trial In Patients With Advanced Cancer And Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00878189).
- A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of…
- A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing’s Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- AAA CEUSIndependent statistical analysis of Evaluation of Contrast-Enhanced Ultrasound to Detect Endoleaks After Endovascular Aortic Aneurysm Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ABEMA Alone or in COMBO With MK-6482: Complete Statistical AnalysisIndependent statistical analysis of ABEMA Alone or in COMBO With MK-6482: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04627064).
- ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size…
- ABLATORIndependent statistical analysis of ABLATOR Ablation Observational Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02344173).
- Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ABSORB EXTENDIndependent statistical analysis of ABSORB EXTEND Clinical Investigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01023789).
- Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058249).
- AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study: Complete Statistical AnalysisIndependent statistical analysis of AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04126187).
- ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: Complete Statistical AnalysisIndependent statistical analysis of ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ACTH Gel Therapy in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of ACTH Gel Therapy in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02030028).
- ACTIVATEIndependent statistical analysis of A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp: Complete Statistical AnalysisIndependent statistical analysis of Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Acupressure in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Acupressure in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05412121).
- AdaProQuoIndependent statistical analysis of Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo: primary endpoint results, effect estimate with confidence interval, sample-size…
- Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer:…
- ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN: Complete Statistical AnalysisIndependent statistical analysis of ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04639024).
- Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Adhese One F Upgrade in Direct Filling Therapy: Complete Statistical AnalysisIndependent statistical analysis of Adhese One F Upgrade in Direct Filling Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02175368).
- ADIOSIndependent statistical analysis of Arrhythmia Detection In Obstructive Sleep Apnea (ADIOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02743520).
- Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation: Complete Statistical AnalysisIndependent statistical analysis of Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ADVANCEIndependent statistical analysis of Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02499679).
- Advance Cardiac Resynchronization Therapy (CRT) Registry: Complete Statistical AnalysisIndependent statistical analysis of Advance Cardiac Resynchronization Therapy (CRT) Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01805154).
- Advisor HD Grid Observational Study: Complete Statistical AnalysisIndependent statistical analysis of Advisor HD Grid Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03733392).
- Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AHAvsSIMIndependent statistical analysis of A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT): primary endpoint results, effect estimate with confidence interval, sample-size…
- AHEADIndependent statistical analysis of Cardiovalve Transfemoral Mitral Valve System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03813524).